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Botch promotes embryonic neurogenesis by inhibit-
ing the initial S1 furin-like cleavage step of Notch
maturation. The biochemical process by which
Botch inhibits Notch maturation is not known. Here,
we show that Botch has g-glutamyl cyclotransferase
(GGCT) activity that deglycinates Notch, which pre-
vents the S1 furin-like cleavage. Moreover, Notch is
monoglycinated on the g-glutamyl carbon of gluta-
mate 1,669. The deglycinase activity of Botch is
required for inhibition of Notch signaling both
in vitro and in vivo. When the g-glutamyl-glycine at
position 1,669 of Notch is degylcinated, it is replaced
by 5-oxy-proline. These results reveal that Botch reg-
ulates Notch signaling through deglycination and
identify a posttranslational modification of Notch
that plays an important role in neurogenesis.
INTRODUCTION
Botch promotes embryonic neurogenesis through inhibition of
Notch1 signaling (Chi et al., 2012). Notch processing and subse-
quent signaling require a S1 furin-like cleavage event (Kopan
and Ilagan, 2009; Louvi and Artavanis-Tsakonas, 2006). This
cleavage generates the mature processed form of Notch in
which one polypeptide becomes divided into the Notch1 extra-
cellular domain (NECD) and the transmembrane intracellular
domain (TMIC). The NECD is the ligand binding domain through
which the ligands, Delta or Jagged-like, activate Notch. The
TMIC upon ligand binding to the NECD will undergo S2 andS3 cleavage to generate the intracellular domain (NICD).
The NICD translocates to the nucleus to direct target gene
expression (Ilagan and Kopan, 2013), where it converts C-pro-
moter binding factor-1 (CBF-1) complex from a transcriptional
repressor to a transcriptional activator resulting in Notch1 target
gene expression. Botch prevents Notch signaling by interfering
with the initial S1 furin-like cleavage step of Notch maturation
(Chi et al., 2012). This maintains Notch in an immature unpro-
cessed form. Botch interferes with the S1 furin-like cleavage
of Notch by physical binding of Botch to the NECD. The mech-
anism of how Botch controls the S1 furin-like cleavage of Notch
is not known. Here, we show that Botch has g-glutamyl cyclo-
transferase (GGCT) activity that deglycinates Notch, which
prevents the S1 furin-like cleavage. The deglycinase activity
of Botch is required for inhibition of Notch signaling, both
in vitro and in vivo. These results reveal that Botch regulates
Notch signaling through deglycination and identify a posttrans-
lational modification of Notch that plays an important role in
neurogenesis.RESULTS
Enzymatic Activity of Botch Is GGCT
The structure of Botch was modeled on the SWISS-MODEL
website (http://swissmodel.expasy.org/), and Botch was found
to closely resemble the structure of human GGCT (Figure 1A).
There is a very high structural similarity between Botch and
GGCT (Figure 1B), even though there is little amino acid (aa)
homology. The SWISS-MODEL search provided a putative
catalytic domain in Botch, which aligned with GGCT, indicating
that it may function in a similar manner. Themodel also predicted
that E115 may be a key aa for Botch enzymatic functionCell Reports 7, 681–688, May 8, 2014 ª2014 The Authors 681
Figure 1. Botch Has GGCT Activity
(A) Botch structure generated by SWISS-MODEL.
(B) Superimposition of Botch (red) structure with
human GGCT structure (green; PDB, 2i5tA)
generated by SWISS-MODEL.
(C) Predicted Botch putative active site residues.
(D) Alignment of human Botch putative active site
residues with corresponding active site residues
of human GGCT.
(E) Schematic representation of GGCT activity.
Glutamate that is modified by an aa on the
g-carbon is removed by the GGCT activity of
Botch, liberating aa and forming 5-oxy-proline.
(F) TLC of g-glutamyl-alanine cleavage by either
recombinant GGCT or Botch, but not Botch-
E115A.
(G) A schematic diagram of the serial reactions by
using oxidation of NADH as the final readout for
Botch’s GGCT-like activity.
(H) Scatchard plot of quantitative activity of control
or Botch or Botch-E115A.
In (F)–(H), experiments were repeated three times
with similar results.(Figure 1C). All the key aa within the catalytic domain of GGCT
could be aligned with Botch (Figure 1D). To determine if Botch
has GGCT activity, thin-layer chromatography (TLC) assays
were performed. In this TLC assay, the g-aa (g-glutamyl-aa) is
converted to the free aa by GGCTs and in the process generates
a 5-oxy-proline (Figure 1E). The free aa is detected by an upward
shift on the TLC plate. A typical GGCT substrate, g-glutamyl-
alanine, was incubated in the presence of GGCT, Botch, or
Botch-E115A. Both GGCT and Botch release alanine by cleav-
age of g-glutamyl-alanine, whereas Botch-E115A is inactive
(Figure 1F). Importantly, Botch does not self-cleave (Figure 1F).
Similar observations are made for g-glutamyl-methionine and
g-glutamyl-glutamate (Figures S1A and S1B). In order to deter-
mine the kinetics of enzymatic function, a well-established quan-
titative biochemical assay to monitor GGCT activity was used
with g-glutamyl-L-alanine as a substrate (Figure 1G) (Oakley
et al., 2008). Botch is active and has a Michaelis-Menten con-
stant (KM) of 1.7 mM, similar to GGCT (Oakley et al., 2008),
whereas Botch-E115A is inactive (Figure 1H). These results indi-
cate that Botch has GGCT-like activity.682 Cell Reports 7, 681–688, May 8, 2014 ª2014 The AuthorsBotch GGCT-like Activity Is
Required for Regulation of
Embryonic Neurogenesis In Vivo
Gain- and loss-of-function studies were
performed as previously described to
explore the role of Botch’s GGCT-like
activity in neocortical development (Chi
et al., 2012). In utero coelectroporation
of pCAG-EGFP and pCAG-Botch or
pCAG-Botch-E115A into embryonic day
13.5 (E13.5) CD1 mouse brain was per-
formed (Figure 2). Embryos were har-
vested at E15.5 and immunostained for
GFP to identify Botch-overexpressing
cells and counterstained with DAPI toidentify all cells. As previously described, Botch overexpression
results in fewer GFP-positive cells in the ventricular and subven-
tricular zones (VZ and SVZ, respectively) and more cells in the
cortical plate (CP) and intermediate zone (IZ) when compared
to coelectroporation with control (pCAG empty vector) (Figures
2B and 2C) (Chi et al., 2012). Botch-E115A has no effect and is
similar to control (Figures 2B and 2C).
To explore the role of Botch’s GGCT-like activity in neurogen-
esis, in utero electroporation of small hairpin RNA (shRNA)
dsRed, shRNA Botch, shRNA-resistant Botch (BotchR), and
shRNA Botch with shRNA-resistant Botch-E115A (BotchR-
E115A) (Figure S2A) into E13.5 CD1mouse brain was performed.
Embryos were harvested at E15.5 (Figures 2D and 2E). Knock-
down of Botch greatly increases the percentage of cells in the
VZ and SVZ while significantly decreasing the percentage of
GFP-positive cells in the CP and IZ (Figures 2D and 2E). Coex-
pression of BotchR, which is not susceptible to shRNA Botch
(Chi et al., 2012), rescues the knockdown phenotype, whereas
BotchR-E115A has no effect (Figures 2D and 2E). Coimmunopre-
cipitation of Botch-E115A-myc with SP-NECD-GFP confirms
Figure 2. Botch GGCT-like Activity Is Required for Regulation of Embryonic Neurogenesis In Vivo
(A) A schematic diagram of pCAG constructs for overexpression (gain of function) for in utero injection and electroporation.
(B–E) Distribution of GFP-positive cells 2 days after in utero injection and electroporation.
(B) Representative confocal images of cortex immunostained for GFP with and without the DAPI channel with Botch expression.
(C) Quantification of distribution of GFP-positive cells in (B). Values represent the mean ± SEM (nR 3). **p < 0.01; ***p < 0.001; n.s. (nonsignificant) p > 0.05, one-
way ANOVA, posttest (Tukey’s multiple comparison tests).
(D) Representative confocal images of cortex immunostained for GFP with and without the DAPI channel following knockdown of Botch and rescue either with
BotchR or BotchR-E115A.
(E) Quantification of distribution of GFP-positive cells in (D). Values represent the mean ± SEM (n R 3). ***p < 0.001; n.s. (nonsignificant) p > 0.05; one-way
ANOVA, posttest (Tukey’s multiple comparison test).
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Figure 3. The GGCT Activity of Botch Is
Required to Block Notch1 Signaling In Vitro
(A) Immunoblots of Notch1 cleavage by furin and
inhibition of furin cleavage by Botch or Botch-
E115A. FL, full-length; IP, immunoprecipitation;
WB, western blot.
(B) Optical densitometry quantification normalized
to immunoglobulin G (IgG) heavy chain. Values
represent the mean ± SEM (n R 3). ***p < 0.001;
n.s. (nonsignificant) p > 0.05 (Student’s t test).
(C) Immunoblot analysis of Notch1 in whole-cell
lysate and surface expression following over-
expression of Botch or Botch-E115A and FLAG-
Notch1-GFP. FL, full-length.
(D) Optical densitometry quantification of (C)
normalized to b-tubulin. Values represent the
mean ± SEM (n = 3). **p < 0.01; ***p < 0.001; n.s.
(nonsignificant) p > 0.05; one-way ANOVA, post-
test (Tukey’s multiple comparison test).
(E) WTCBF-1 luciferase reporter assays of HeLa
cells expressing Notch1 and either Botch or
Botch-E115A cocultured with NIH 3T3 cells ex-
pressing Notch ligands. WTCBF-1 luciferase
activity was normalized to b-gal activity and then
to the Mock group without Botch. Values repre-
sent the mean ± SEM (n R 3). ***p < 0.001; n.s.
(nonsignificant) p > 0.05, one-way ANOVA, post-
test (Tukey’s multiple comparison test).that this mutant can bind Notch1 (Figure S2B) and supports the
notion that inactivity of Botch-E115A during neurogenesis is due
to a lack of catalytic activity. These results taken together indi-
cate that Botch’s GGCT-like activity is required for Botch’s pro-
motion of neurogenesis.
BotchBlocksNotchSignaling In Vitro throughGGCT-like
Activity
Botch promotes neurogenesis by preventing the cell surface
presentation of Notch by inhibiting the S1 furin-like cleavage
of Notch, maintaining Notch in the immature full-length form
(Chi et al., 2012). To determine whether the GGCT-like activity
of Botch is required for the regulation of S1 cleavage of
Notch1, FLAG-Notch1-EGFP (FLAG-N1-GFP) was treated
with furin in the presence or absence of Botch or Botch-
E115A. As previously reported, wild-type (WT) Botch com-
pletely prevents the furin cleavage of Notch1 (Chi et al.,
2012), whereas Botch-E115A is devoid of activity (Figures 3A
and 3B). To determine if Botch acts generally on proteins that
are furin substrates, we investigated whether Botch can
inhibit the cleavage of proBMP10 (Susan-Resiga et al., 2011).
Botch fails to block the furin cleavage proBMP10 to BMP10
(Figure S3).684 Cell Reports 7, 681–688, May 8, 2014 ª2014 The AuthorsTo further investigate the actions of
Botch on Notch, Botch and Notch1 GFP-
tagged constructs were expressed in
human embryonic kidney 293 (HEK293)
cells to monitor Notch1 processing.
Overexpression of Botch leads to an
approximate 2-fold increase in unpro-
cessed full-length Notch1 (Notch1-FL)with a significant decrease in the NECD (Figures 3C and 3D).
Botch-E115A has no effect (Figures 3C and 3D). HeLa cells
were transfected with Notch1-FL and 43 WTCBF-1 response
element luciferase reporter, and b-galactosidase (b-gal) reporter
and Botch or Botch-E115A. HeLa cells were cocultured 24 hr
later with NIH 3T3 cells expressing the ligand Delta-like 1 (DII1)
or Jagged 1 (JI). b-gal and luciferase activity was determined
24 hr after coculture. Botch significantly inhibits the activation
of CBF-luciferase activity, whereas Botch-E115A has no effect
(Figure 3E). These results indicate that Botch blocks Notch1
signaling through inhibition of the furin-like cleavage of Notch1
via its GGCT-like activity.
Botch Deglycinates Notch1, and Notch E1669 Is
Required for Botch to Block Notch Signaling
Because Botch liberates aa from g-carbon-modified glutamate
(g-glutamyl-aa) (see Figures 1 and S1), experiments were per-
formed to determine whether Notch1 has g-carbon-modified
glutamates. Because Botch binds to the full-length unprocessed
Notch1 at the extracellular domain containing the epidermal
growth factor (EGF) repeat 32–36 plus Lin12/Notch repeats
(LNR) domains corresponding to aa 1,224–1,723 (Chi et al.,
2012), Notch1 1,224–1,723 was fused downstream to the
Figure 4. Botch Deglycinates Notch1, and
Notch1 E1669 Is Required for Botch toBlock
Notch1 Signaling
(A) TLC of g-glutamyl-glycine cleavage by either
recombinant GGCT or Botch, but not Botch-
E115A (n = 3).
(B) TLC of NECD liberation of glycine by Botch.
Four reference aa were run along with the cleav-
age product.
(C) Immunoblots of Notch1 or Notch1-E1669Q
cleavage by furin. FL, full-length.
(D) Optical densitometry quantification of a
normalized to IgG heavy chain. Values represent
the mean ± SEM (n R 3). ***p < 0.001; n.s.
(nonsignificant) p > 0.05 (Student’s t test).
(E) Immunoblot analysis of Notch1 in whole-cell
lysate and surface expression following over-
expression of Botch and FLAG-Notch1-GFP or
FLAG-Notch1-E1669Q-GFP.
(F) Optical densitometry quantification of (E)
normalized to b-tubulin. Values represent the
mean ± SEM (n = 3). **p < 0.01; n.s. (nonsignifi-
cant) p > 0.05; one-way ANOVA, posttest (Tukey’s
multiple comparison tests).20 aa N terminus signal peptide from Notch1 to ensure proper
subcellular localization, andwas overexpressed, immunoprecip-
itated, and purified from HEK293 cells (Figure S4A). A Notch1
peptide spanning 832–1,310 also containing the 20 aa N termi-
nus signal peptide from Notch1 served as a control (Figure S4A).
The bands corresponding to Notch 1,224–1,723 and 832–1,310
were excised and subjected to trypsin digestion andmass spec-
trometry analysis. A total of 31 nonredundant tryptic peptides
that contain 72% glutamate (21 out of 29) were observed and
mapped to 63% of aa of Notch 1,225–1,723. Using a targeted
approach focused on glutamate residues in Notch1, mass spec-
trometry reveals that three glutamates including glutamate 1,669
are modified by glycine (Figure S4B). If glycine is removed from
g-glutamyl-glycine, via the GGCT-like activity of Botch, a 5-oxy-
proline, which has a unique mass different from all other aa,
should be formed (Figure S4C). As such, the mass spectrometry
data were analyzed for 5-oxy-proline, and it was determined thatCell Reports 7, 681the g-glutamyl-glycine at position 1,669
is replaced by 5-oxy-proline (Figure S4D).
A 5-oxy-proline substitution was not de-
tected at positions 1,595 or 1,655. Gluta-
mate 1,669 is conserved between the
mammalian Notchs as well as Drosophila
(Figure S4E). These results suggest that
Notch glutamate 1,669 is modified via
glycine on the g-carbon and undergoes
removal to create a 5-oxy-proline.
Botch Deglycinates Notch1
To determine if Botch has GGCT activity
against g-glutamyl-glycine, TLC assays
were performed. The substrate g-glu-
tamyl-glycine was incubated in the pres-
ence of GGCT, Botch, or Botch-E115A.Both GGCT and Botch release glycine by cleavage of g-glu-
tamyl-glycine, whereas Botch-E115A is inactive (Figure 4A). To
ascertain whether Botch is able to release glycine from Notch1,
the NECD that binds to Botch (NECD1-GFP) was expressed and
purified and incubated with purified Botch. TLC analysis reveals
a band at the correct migration for glycine, but not glutamate,
alanine, or leucine (Figure 4B). A migration factor (Rfx100) was
calculated at 26 and confirms that the band detected by TLC
migrates identically to glycine (Sleckman and Sherma, 1982)
(Figure 4B).
Notch E1669 Is Required for Furin-like Cleavage of
Notch and Botch-Dependent Regulation of Notch
Signaling
To determine if E1669 is required for the furin-like cleavage of
Notch1, a conservative aa substitution from glutamate to gluta-
mine was made at 1,669 in Notch1-FL (FLAG-N1-E1669Q-GFP).–688, May 8, 2014 ª2014 The Authors 685
FLAG-N1-GFP or FLAG-N1-E1669Q-GFP was treated with furin
in the presence or absence of Botch. WT Notch1 is cleaved by
furin, whereas FLAG-N1-E1669Q-GFP is not (Figures 4C and
4D). Botch is without effect on FLAG-N1-E1669Q-GFP (Figures
S4F and S4G). Botch-myc binds to SP-NECD-E1669Q-GFP
Botch (Figures S4H and S4I). To further investigate the impact
of the E1669Q mutation on the processing of Notch, WT FLAG-
N1-GFP or FLAG-N1-E1669Q-GFP in the presence or absence
of Botch was expressed in HEK293 cells to monitor Notch1
processing. Similar to the effects of Botch overexpression,
Notch1-E1669Q leads to an approximate 3-fold increase in un-
processed Notch1-FL with a significant decrease in the NECD
(Figures 4E and 4F) but has no effect on FLAG-N1-E1669Q-GFP
processing.
DISCUSSION
The major finding of this study is that Botch functions as a GGCT
to remove glycine from a g-carbon-modified glutamate on
Notch1. This results in the loss of the furin-like cleavage of
Notch1-FL, leading to decreased cell surface expression of
Notch1 and inhibition of Notch1 signaling and regulation of neu-
rogenesis. Botch’s GGCT-like activity is required for the promo-
tion of neurogenesis and the inhibition of Notch1 signaling. By
mass spectrometry and mutational analysis, a critical glutamate
was found in human Notch1 that is required for Notch1’s furin-
like cleavage. Posttranslation modification via monoglycination
on glutamate 1,669 appears to be required for the furin-like
cleavage of Notch1 because a conservative substitution of gluta-
mate 1,669 to glutamine in Notch1 prevents its furin-like cleav-
age, similar to the effect of Botch removing the glycine from
the g-glutamyl-modified glutamate in Notch1.
In mammalian cells, biochemical studies indicate that S1
cleavage of the extracellular domain by furin protease, a propro-
tein convertase, leads to maturation of the Notch receptor. This
cleavage and creation of the heterodimeric form of Notch occur
in the Golgi apparatus, where Notch and Botch interact (Chi
et al., 2012). Although there is substantial evidence in mamma-
lian systems for the importance of S1 cleavage, the generality
of this event across species is controversial. In Drosophila,
in which Notch was first discovered, the furin cleavage of
Drosophila Notch has long been controversial (Kidd and Lieber,
2002). However, recent investigations with new reagents and
approaches provide strong evidence that the Drosophila Notch
requires S1 cleavage (Lake et al., 2009). To explore the generality
of Botch regulation of Notch, S2 Drosophila cells were trans-
fected with full-length Drosophila Notch-VP16 (pANLV) (Saj
et al., 2010), a Notch-responsive NRE luciferase reporter or a
Notch-unresponsive NRE mutant luciferase reporter, b-gal and
a Drosophila Botch WT expression construct, and a Botch
GGCT mutant construct with an E135A mutation, which corre-
sponds to the E115A mutation (Chi et al., 2012). In pANLV-trans-
fected S2 cells, Botch significantly inhibits the activation of
Notch, whereas Botch-E135A has no effect (data not shown),
suggesting that Botch blocks Notch1 signaling through inhibition
of the furin-like cleavage of Notch1 via its GGCT-like activity and
that this activity appears to be evolutionarily conserved. Future
studies are required to clarify the role of Botch’s potential regu-686 Cell Reports 7, 681–688, May 8, 2014 ª2014 The Authorslation of Drosophila Notch, similar to those outlined here for
mammalian Notch1.
Our study focuses on the regulation of Notch1 by Botch, but it
is notable that the Notch isoforms have been observed to have a
differential requirement for S1 cleavage. Although S1 cleavage
appears important for the maturation of Notch1, mutation of
the S1 cleavage site in Notch2 has no apparent effect on trans-
port of Notch2 to the cell surface or subsequent signaling events
(Gordon et al., 2009). Thus, although Botch can potentially block
the S1 cleavage of all Notch receptors, it might inhibit Notch
signaling in a paralog-specific manner through interference
with Notch1 signaling while sparing Notch2 signaling. Given
that the number and isoform type of cell surface Notch receptors
are critical for the functional outcome of Notch signaling, the
control of processing events provides an important layer of
control that can have important biological and therapeutic
implications.
When g-glutamyl-glutamate is cleaved to remove the aamodi-
fication, it creates a unique 5-oxy-proline. Consistent with this
idea, we observed a 5-oxy-proline modification at position
1,669 in Notch1, the same aa we found by mass spectrometry
to be modified by glycine. Mutations in human Notch that flanks
this conserved E1669 prevent furin cleavage, resulting in T cell
acute lymphoblastic leukemias, supporting the idea that this
site is important for Notch function (Van Vlierberghe and Fer-
rando, 2012).
The posttranslational modification of proteins on g-glutamyl-
glutamate by aa has been described for tubulin, 14-3-3, nucleo-
some assembly protein 1 (NAP1), and others (Lalle et al., 2011;
van Dijk et al., 2008; Wloga et al., 2010; Wloga and Gaertig,
2010). Tubulin ligase-like (TLL) 3 and 4 ligate glycine or glutamate
to tubulin on the g-carbon of glutamate where they are then elon-
gated via TLL10 in Drosophila to form polyglycine or polygluta-
mate side chains that modify tubulin function (Rogowski et al.,
2009). The mechanism by which Notch1 is glycinated is not
known, but TLLs are likely candidates. Notch1 appears to be
monoglycinated because we were unable to detect polyglycine
chains on Notch1 via mass spectrometry. This is consistent
with the observation in humans that TLL10, which is required
for the polyglycination, is inactive (Rogowski et al., 2009).
Carboxypeptidase 5 (CCP5) acts as a tubulin deglutamylase (Ki-
mura et al., 2010). The mechanism by which g-glutamyl-glycines
are removed is not known. The finding that Botch acts as a de-
glycinase suggests that Botch represents a previously unknown
deglycinase. Consistent with this notion is the observation that
YER63C, the yeast homolog of Botch, was recently shown to
possess GGCT activity where it converts glutathione to 5-oxy-
proline and the dipeptide cysteine-glycine (Kumar et al., 2012).
Thus, Botchmay regulate other proteins that are posttranslation-
ally modified with the addition of glycine to the g-carbon of
glutamate.
In summary, we identify a posttranslational modification in
which the g-glutamyl-glycine of Notch1 at position 1,669 is
removed by the GGCT activity of Botch. This prevents the S1
furin-like ‘‘cleavage’’ of Notch1, maintaining it in an inactive
state. These findings expand the repertoire of proteins that
undergo posttranslational modification on the g-carbon of gluta-
mate. Because there are other GCCT-like proteins, there are
likely to be other proteins that are regulated by posttranslation aa
addition and removal. These findings have the potential to open
up a new area of investigation into this understudied posttrans-
lational modification and the biologic consequences of regula-
tion of this modification.
EXPERIMENTAL PROCEDURES
Plasmid Constructs and Vector-Based shRNA Constructs
Botch cDNA from rat brain (GenBank NM_001173437.1) was cloned into
pcDNA3.1/myc/His (Invitrogen) and APTag5 (GenHunter) as previously
described (Chi et al., 2012; Saj et al., 2010). For the rescue experiments,
BotchR and shRNA-dsRed were generated as previously described (Chi
et al., 2012). The extracellular domain of Notch1 (NECD1) contains a cDNA
fragment from 227 to 5,395 bp of rat Notch1 cDNA (NM_001105721.1). The
NECD1 was further divided into four fragments including EGF repeats 1–12,
11–24, 22–33, and 32–36 with LNR, which contain cDNA fragments from
227 to 1,705 bp, 1,472 to 2,956 bp, 2,723 to 4,156 bp, and 3,899 to
5,395 bp, respectively. To ensure proper processing, the cDNA encoding
the 20 aa signal peptide from Notch1 was inserted into the N-terminal of
each NECD1 fragment by PCR. Botch-E115A mutant and Notch1-E1669Q
mutant were generated by site-directed mutagenesis (Stratagene) and verified
by sequencing. Human GGCT cDNA (GenBank C7orf24) was subcloned into
pGEX-6p-1 vector (GE Healthcare).
In Utero Injection and Electroporation
DNA transfer into E13.5 CD1 mouse brains in utero was performed using a
NEPA GENE CUY21 EDIT electroporator. A total of 2.5 mg of DNA constructs
in PBS was injected into the lateral ventricle using an orally controlled capillary
micropipette. Five electric pulses (33 V, 50 ms pulse followed by 950 ms gap)
were delivered. Embryos were harvested at E15.5 fixed in 4% paraformalde-
hyde with 30% sucrose dehydration. A total of 0.5 mg shRNA-Botch-pCAG-
EGFP or shRNA-dsRed-pCAG-EGFP was coinjected with 2 mg mock (pCAG
empty vector), pCAG-BotchR, pCAG-BotchR-E115A, or pCAG-Botch plas-
mids. A total of 1 mg pCAG-EGFP was coinjected with 1 mg of mock (pCAG
empty vector), pCAG-Botch, or pCAG-Botch-E115A plasmid. All animal sub-
ject research was approved by the Animal Care and Use Committee at Johns
Hopkins University School of Medicine.
TLC Assay
TLC assays were performed as described by Sleckman and Sherma (1982) on
silica gel 60A plates (Whatman) with n-butanol/acetic acid/water, 3:1:1. Chro-
matography plates were dried and developed with Ninhydrin (Sigma-Aldrich)
to produce blue or purple zones of aa. GGCT-glutathione S-transferase
(GST) fusion protein cloned into pGEX-6P-1 vector was expressed in E. coli.
Botch protein was purified with glutathione Sepharose 4B, and the GST tag
was cleaved by PreScission Protease (GE Healthcare). Alkaline phosphatase
(AP) or Botch tagged with Botch-AP or Botch-E115A-AP constructs was tran-
siently transfected into HEK293 cells (Chi et al., 2012). The conditioned
medium containing the Botch-AP fusion protein was centrifuged, pH adjusted,
concentrated, and filtered. Concentration was determined by p-Nitrophenyl
phosphate (GenHunter) at 405 nm.
Characterization of Botch-AP Enzymatic Activity
An enzymatic activity assay was performed as described previously (Oakley
et al., 2008). The activity of AP, Botch-AP, or Botch-E115A-AP was measured
with g-glutamyl-L-alanine as a substrate by using oxidation of NADH as the
final readout.
Cell Cultures
HEK293, HeLa, and NIH 3T3 cells were obtained from the American Type
Culture Collection.
CBF-1RE and NRE Luciferase Reporter Assay
The coculture reporter assay was performed as described (Chi et al., 2012).
WT-CBF-1RE reporter constructs were provided by D. Hayward (JohnsHopkins University School of Medicine). WT and mutant NRE luciferase re-
porter constructs were made by S. Bray (University of Cambridge).
Immunoprecipitation Assays
The immunoprecipitation protocols were as described (Zhang et al., 2000).
Protein G Sepharose beads, 5 mg anti-GFP (Rockland), or 5 mg anti-Notch1
(C20; Santa Cruz Biotechnology) was used. In HEK293 cell lysates, heterodi-
meric Notch1 is dissociated by 1% Triton X-100.
Immunoblot Analysis and Immunostaining
Primary antibodies used were rabbit anti-Notch1 (Millipore), mouse anti-Botch
(NeuroMab; 75-181), mouse anti-myc (Sungene), goat anti-GFP (Rockland),
and mouse anti-b-tubulin (Sigma-Aldrich). Immunostainings were imaged
with a Zeiss LSM 510. Images were processed with Adobe Photoshop.
Cell Surface Biotinylation Labeling
Biotin was used to label and isolate cell surface protein as described (Chi et al.,
2012).
Furin Cleavage Assay
As previously described (Chi et al., 2012), HEK293 cells were transfected with
FLAG-Notch1-GFP construct. The cell lysates were subjected to anti-GFP
immunoprecipitation 24 hr later. The FLAG-Notch1-GFP binding on protein
G beads was first pretreated with AP, Botch-AP, or Botch-E115A-AP and
then treated with furin (New England Biolabs) at room temperature in a total
volume of 1 ml using 20 U of recombinant furin in 100 mM HEPES 7.5, 0.5%
Triton X-100, and 1 mM CaCl2.
Statistical Analysis
Statistical analysis was performed using Prism or Excel software, and specific
tests are noted in the text and figure legends. Unless otherwise noted, all error
bars represent ±SEM, and significance was assessed as p < 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
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